Connect with us

Government

11 Reasons Why This Was Joe Biden’s Worst Week Ever

11 Reasons Why This Was Joe Biden’s Worst Week Ever

Authored by Michael Snyder via The Economic Collapse blog,

Joe Biden has had a lot of bad weeks over the last 12 months, but this week has got to take the cake.  In fact, it is hard to…

Published

on

11 Reasons Why This Was Joe Biden's Worst Week Ever

Authored by Michael Snyder via The Economic Collapse blog,

Joe Biden has had a lot of bad weeks over the last 12 months, but this week has got to take the cake.  In fact, it is hard to remember the last time that any president had a week that was this bad.  But this wasn’t supposed to happen.  Democrats were promising a return to “normalcy” after the Trump years, but instead virtually everything seems to be going wrong.  No matter where you are on the political spectrum, you should be able to admit that Joe Biden’s presidency is not going very well at all.  At this point, even many Democrats are using the word “failure” to describe Biden, and this is fueling rumors that Hillary Clinton may run again in 2024.

Yes, Biden’s presidency has been such a complete and utter disaster that the absolutely unthinkable could actually become a reality.

Just when you think that things can’t get any worse, somehow they do.  The following are 11 reasons why this was Joe Biden’s worst week ever…

#1 The OSHA Mandate

On Thursday, we learned that the U.S. Supreme Court had voted 6 to 3 to strike down Biden’s cherished OSHA vaccine mandate…

President Biden urged businesses to bring in vaccine mandates on their own and pushed states to ‘do the right thing’ after the Supreme Court voted 6-3 to block his sweeping rules on private companies in a crushing blow to his pandemic response.

The high court did however allow a vaccine mandate for employees at health care facilities receiving federal dollars to go into effect.

The OSHA mandate would have covered approximately 80 million American workers, and countless workers all over the country that would have lost their jobs under this mandate are greatly celebrating right now.

#2 The Filibuster

Biden was desperately hoping that all of the Democrats in the U.S. Senate would agree to kill the filibuster so that he could get the “voting rights bill” through Congress, but Senator Kyrsten Sinema just made it exceedingly clear that she is not willing to do that

First, Arizona Sen. Kyrsten Sinema, a fellow Democrat, announced that although she supports the voting rights bill, she’s not willing to do what it would take to make it happen. The filibuster. I’m talking about killing the filibuster.

This came only two days after the president made such an impassioned speech in support of knocking off the filibuster that Republicans essentially called it offensive. And even one Democratic senator said Biden, who pledged a year ago to unite Americans, went too far in the speech.

When she was elected, I never imagined that the day would come when I would be thankful for Kyrsten Sinema.

But today I am definitely very thankful that she has taken this stand.

#3 Inflation

This week, it was announced that the inflation rate had hit a 40 year high, and Americans are blaming Biden for this.

And as I pointed out in an article that I posted on Wednesday, if inflation was still calculated the way that it was back in 1980, the official rate of inflation in this country would be above 15 percent at this point.

#4 Shortages

In December, Joe Biden told the nation that the supply chain crisis was over.

Of course that was not true, and now store shelves are so empty that “BareShelvesBiden” has been trending on social media throughout this entire week.

#5 Joe Biden’s Approval Rating

At the beginning of his presidency, Biden actually had very strong approval ratings, but now they just continue to sink lower and lower.

As I pointed out yesterday, the seven most recent Quinnipiac polls show a very clear trend

President Biden’s overall approval rating in the last seven Quinnipiac polls: 49%, 46%, 42%, 38%, 37%, 36%, 33%.

[ZH: The dead-cat-bounce in Biden's approval is over...]

#6 Fauci’s Approval Rating

Dr. Fauci was Biden’s handpicked choice to lead the U.S. out of this pandemic, but he has been steadily losing the trust of the American people.

According to a NewsNation poll that was just conducted, only 31 percent of all Americans still believe what he is telling us about the pandemic.

#7 Omicron

During the presidential campaign, Joe Biden repeatedly promised that he would “shut down the virus”, but in recent days the number of COVID cases has soared to all-time record highs in the United States.  At this point things are so bad that even Biden administration officials are admitting that essential services are in danger of totally breaking down

Acting Food and Drug Administration Commissioner Dr. Janet Woodcock gave U.S. lawmakers an ominous warning this week: The nation needs to ensure police, hospital and transportation services don’t break down as the unprecedented wave of omicron infections across the country forces people to call out sick.

“It’s hard to process what’s actually happening right now, which is most people are going to get Covid,” Woodcock testified before the Senate health committee on Tuesday. “What we need to do is make sure the hospitals can still function, transportation, other essential services are not disrupted while this happens.”

#8 The Lack Of COVID Tests

Even CNN and MSNBC have been roasting Biden this week for not having enough COVID tests for the American people.

Now the Biden administration is telling us that millions of new tests are on the way, but by the time they arrive the Omicron wave may be over.

#9 Russia

Foreign policy takes a great deal of finesse, and that is something that Biden’s team is sorely lacking.

When I first started warning that Biden was surrounded by the worst foreign policy team in U.S. history, a lot of people thought that I was exaggerating.

But now the truth is becoming very clear, and a potential war with Russia that nobody wants is closer than ever

Talks to find a diplomatic solution to the worsening situation between Russia and Ukraine are on the brink of collapse after Thursday’s meeting as a key US ambassador warned ‘the drumbeat of war is sounding loud.’

Secretary of State Antony Blinken hit the airwaves on Thursday morning where he also weighed in on the crisis, claiming the ‘jury is still out’ on whether Russian President Vladimir Putin’s aggressive military buildup on Ukraine’s border will end with an invasion.

#10 Kamala Harris

Is even Kamala Harris turning against Biden?

This week, a reporter asked Harris if the Democrats would have the same presidential ticket in 2024.

Normally, that would be a really easy question for any vice-president to answer.

But instead of answering “of course”, this is how Harris responded

REPORTER: “Are we going to see the same Democrat ticket in 2024?”

HARRIS: “[long pause] I’m sorry but we are thinking about today”

Wow.

I think that this is another very clear sign that there is far more going on behind the scenes than we are being told.

#11 Hillary Clinton

Biden is such a failure that some Democrats are already suggesting that Hillary Clinton should be the Democratic nominee in 2024.

Seriously.

On Wednesday, a pro-Hillary piece authored by two key Democratic operatives named Douglas E. Schoen and Andrew Stein appeared in the Wall Street Journal.  In their article, they listed a number of different reasons why they believe that Hillary would be a good choice for the next election cycle…

‘Several circumstances – President Biden’s low approval rating, doubts over his capacity to run for re-election at 82, Vice President Harris’s unpopularity, and the absence of another strong Democrat to lead the ticket in 2024 – have created a leadership vacuum in the party, which Mrs. Clinton viably could fill,’ they write.

So could we actually see a rematch between Hillary Clinton and Donald Trump?

Of course we still have three more years of the Biden/Harris administration to get through first, and that won’t be pleasant.

Decades of very foolish decisions set the stage for where we are today, and now Biden and his minions have us steamrolling down a highway that doesn’t lead anywhere good.

By the time we get to 2024, this country could be completely unrecognizable.

Biden’s first year has been absolutely terrible, and the next three years are likely to be even worse.

But there is no “exit button” on this ride, and so we are all going to have to endure whatever is coming next.

*  *  *

It is finally here! Michael’s new book entitled “7 Year Apocalypse” is now available in paperback and for the Kindle on Amazon.

Tyler Durden Fri, 01/14/2022 - 16:20

Read More

Continue Reading

Government

AMC CEO Looks To Refinance Debt Amid Dip In Stock Price

A skittish stock market and a struggling box office are complicating the theater chain’s attempts to turn around its debt situation.

Published

on

A skittish stock market and a struggling box office are complicating the theater chain’s attempts to turn around its debt situation.

Let’s give credit where it’s due. Most people don’t follow through with their New Year’s Resolutions, but at least AMC Entertainment (AMC) - Get AMC Entertainment Holdings, Inc. Class A Report CEO Adam Aron is trying.

Following a Tweet earlier this month in which the head of the beleaguered movie theater chain announced plans to “refinance some of our debt to reduce our interest expense, push out some debt maturities by several years and loosen covenants,” he’s now making moves to try to get the job done. 

Aron has reportedly been “in advanced talks with multiple parties” about refinancing, according to The Wall Street Journal. But the ongoing volatility of the stock market, amongst other factors, is complicating matters.

Irfan Khan / Los Angeles Times via Getty Images

Rough Years For AMC

To make it through the pandemic, AMC ended up having to take on a great deal of debt. It reportedly owed $5.5 billion as of last September and also owed $376 million worth of lease payments, which were deferred for a while during the pandemic. 

But as we’ve previously mentioned, the past few years have been tough for theater chains such as AMC. Even before the pandemic put a pause on theater-going in 2020, leading to an absolutely brutal total box office gross drop of 81.4%, general audiences were increasingly only heading out to movie theaters for blockbuster films and franchise installments, often from the Marvel Cinematic Universe or the “Fast & Furious.”

AMC had a reported net loss of $13.5 million in 2019, even as total revenue was up 2.4% to $1.44 billion from the year before. Things improved for the company last year once people felt safe returning to the theaters, as access to vaccines helped unlock some pent-up demand, and the box office rose by 112.5% to $4,468,850,254. 

A big chunk of that rebound is due to the jaw-dropping success of “Spider-Man: No Way Home,” which recently returned to the top of the box office, on its way to making $1.69 billion worldwide. (Will Peter Parker eventually conquer the blue aliens from “Avatar” to become the highest-grossing film of all time? Stay tuned.) 

But you can’t turn around a struggling industry based on the success of one film, and even Marvel and Disney  (DIS) - Get Walt Disney Company Report can’t put out a general-audience pleasing blockbuster every week. 

Even with a new “Scream” film out, last weekend’s box office total barely totaled more than $43 million, a far cry from five years ago. “That's down from a pre-pandemic $105 million in 2020, $73 million in 2019, $102 million in 2018, and $111 million in 2017, according to data from Box Office Mojo.”

Memes Saved AMC (For A Little While)

Last year AMC received an unexpected lifeline when it became the subject of an internet-driven rush that turned it into a short-lived meme stock. 

After a Reddit-incubated army of internet investors, who dubbed themselves “apes,” began buying shares in AMC through trading applications such as Robinhood, shares of the company temporarily rose to a robust $62.55 a share. Prices would eventually return to earth, hitting $35 a share after the hype dropped down. But the boost allowed Aron to buy the company some time. 

AMC used the cash infusion to repurchase $35 million worth of debt that carried a minimum interest rate of 15%, according to Yahoo! Finance. The deal cost $41.3 million, but it is expected to reduce the overall annual interest on its debt by about $5.3 million.

This year Aron is stepping up his efforts to refinance AMC’s debt, but it’s rough out there at the moment. 

Amid Wall Street’s current market contraction, AMC’s stock has dropped by 41% this year, erasing the meme stock gains, and AMC’s $1.5 billion in secured 10% bonds “traded as low as 92 cents on the dollar, down from 99.5 cents at the start of the year,” according to The Wall Street Journal. 

AMC isn’t looking to refinance all of its debt. Instead, it is targeting some of the bonds with especially high interest, as a way to cut expenses even as bond prices continue to drop.

But it seems like the meme stock rush has turned out to be a double-edged sword. 

AMC was able to stay in business by “selling new shares, taking on new debt, and getting landlords to agree to delay collecting rent payments.” But meme investors have objected to Aron’s plans to allow more AMC shares to be sold, out of fear that it would dilute what they’ve already purchased. 

Aron and AMC have a skittish-at-best stock market and an industry that is struggling to get people into theaters for all but event films. On the other hand, it has a loyal group of investors that are nonetheless limiting the company’s options. 

Read More

Continue Reading

Government

About 35% of People Who Received Placebo in Vaccine Trials Report Side Effects and More COVID-19 News

According to a recent study conducted by researchers at Harvard Medical School and Beth Israel Deaconess Medical Center, 76 percent of the adverse side effects (such as fatigue or headache) that people experienced after receiving their first COVID-19…

Published

on

About 35% of People Who Received Placebo in Vaccine Trials Report Side Effects and More COVID-19 News

The placebo effect is where a person who received a placebo instead of a drug or vaccine shows clinical signs, positive or negative, associated with the actual treatment. Much has been made about the side effects of the COVID-19 vaccines, but a new study found a startlingly high number of adverse events associated with people who received placebos in clinical trials. For that and more COVID-19 news, continue reading.

COVID-19 Vaccine Side Effects: Real or Placebo Effect?

A recent study out of Harvard Medical School and Beth Israel Deaconess Medical Center evaluated 12 COVID-19 vaccine trials with a total of 45,380 participants. The study found that 76% of the adverse side effects reported, such as fatigue or headache, after the first shot were also reported by participants who received a placebo. Mild side effects were more common in people receiving the vaccine, but a third of those given the placebo reported at least one adverse side effect. The statistics from the study showing that 35% of placebo recipients reported adverse side effects is considered unusually high. Several experts suspect that there’s such a high report of adverse events because of the amount of misinformation found on social media about the dangers of the vaccines and the amount of media coverage.

This is not to say that the adverse side effects felt by people who received the vaccines are all in their heads. People do have side effects to vaccines, but this study reports on an unusually high level of the placebo effect. Nocebo is used to describe a negative outcome associated with the placebo.

Source: BioSpace

“Negative information in the media may increase negative expectations towards the vaccines and may therefore enhance nocebo effects,” said Dr. Julia W. Haas, an investigator in the Program in Placebo Studies at Beth Israel Deaconess and the study’s lead author. “Anxiety and negative expectation can worsen the experience of side effects.”

Four Factors for Long COVID

A study published in Nature Communications identified specific antibodies in the blood of people who developed long COVID. Long COVID is not well understood and has a range of up to 50 different symptoms, and it is difficult to diagnose because there is no one test for it. The study, conducted by Dr. Onur Boyman, a researcher in the Department of Immunology at University Hospital Zurich, compared more than 500 COVID-19 patients and found several key differences in patients who went on to present with long COVID. The most obvious was a significant decrease in two immunoglobulins, IgM and IgG3. The study found that a decrease in these two immunoglobulins, which generally rise to fight infections, combined with other factors, such as middle age and a history of asthma, was 75% effective in predicting long COVID.

75% of COVID-19 ICU Survivors Show Symptoms a Year Later

A study out of the Netherlands found that a year after being released from an intensive care unit (ICU) for severe COVID-19, 75% of patients reported lingering physical symptoms, 26% reported mental symptoms, and up to 16% noted cognitive symptoms. The research was published in JAMA. The research evaluated 246 COVID-19 survivors treated in one of 11 ICUs in the Netherlands. The mental symptoms included anxiety (17.9%), depression (18.3%), PTSD (9.8%). The most common new physical symptoms were weakness (38.9%), stiff joints (26.3%), joint pain (25.5%), muscle weakness (24.8%), muscle pain (21.3%) and shortness of breath (20.8%).

Pennsylvania Averaging Most COVID-19 Deaths Per Day in a Year

In general, COVID-19 deaths are dropping across the country. However, in two states, Pennsylvania and New Jersey, the numbers are increasing. Pennsylvania is averaging 156 COVID-19 deaths per day over the past seven days, which is a 17% uptick compared to two weeks ago. The number of deaths per day in Pennsylvania is below what was hit in January 2021, largely due to the availability of vaccines. New Jersey averages 111 deaths from COVID-19 per day, an increase of 61% over the last two weeks and the highest since May 2020. Similarly, New Jersey cases and hospitalizations are declining.

Omicron Surge: Shattering Cases and Hospitalizations, but Less Severe

According to the CDC, although the current Omicron surge is setting records for positive infections and hospitalizations, it’s less severe than other waves by other metrics. Omicron has resulted in more than 1 million cases per day in the U.S. on several occasions, and reported deaths are presently higher than 15,000 per week. However, the ratio of emergency department visits and hospitalizations to case numbers is lower compared to COVID-19 waves for Delta and during the winter of 2020–21. ICU admissions, length of stay, and in-hospital deaths were all lower with Omicron. They cite vaccinations and booster shots as the likely cause. Although the overall result is that Omicron appears less severe, it’s not completely clear if that’s because the viral variant doesn’t infect the lower lung as easily as other variants, or because so much of the population has either been vaccinated or exposed to the virus already. It is clearly far more infectious than other strains, which is placing a real burden on healthcare systems. The number of emergency department visits is 86% higher than during the Delta surge.

J&J Expects Up to $3.5 Billion in COVID-19 Vaccine Sales This Year

Johnson & Johnson projected annual sales of its COVID-19 vaccine for 2022 to range from $3 billion to $3.5 billion. This was noted during the company’s fourth-quarter 2021 report. In December 2021, the U.S. Centers for Disease Control and Prevention recommended the PfizerBioNTech or Moderna shots over J&J’s due to a rare blood condition observed with the J&J shot. By comparison, Pfizer and BioNTech project their vaccine will bring in $29 billion in 2022, after having raked in almost $36 billion in 2021. Moderna expects approximately $18.5 billion this year, with about $3.5 billion from possible additional purchases. Although final figures for Moderna aren’t in yet, they projected 2021 sales between $15 and $18 billion.

BioSpace source:

https://www.biospace.com/article/about-35-percent-of-people-receiving-placebo-in-vaccine-trials-report-side-effects-and-more-covid-19-news

Read More

Continue Reading

Spread & Containment

COVID-19 cases at highest ever in Americas – regional health agency

New cases of COVID-19 in the Americas in the past week were the highest since the pandemic began and the very contagious Omicron variant has clearly become the predominant strain, the Pan American Health Organization said on January 26.

Published

on

COVID-19 cases at highest ever in Americas – regional health agency

BRASILIA, Jan 26 (Reuters) – New cases of COVID-19 in the Americas in the past week have been the highest since the pandemic began in 2020 and the very contagious Omicron variant has clearly become the predominant strain, the Pan American Health Organization said on Wednesday.

There were more than 8 million new cases, 32% higher than the previous week, while fatalities throughout the region also increased by 37%, with 18,000 new deaths caused by COVID-19.

The United States continues to have the highest number of new infections, although cases decreased by nearly 1 million over the last week, the regional health agency said.

Mexico’s southern states have seen new infections triple and Brazil has seen new cases surge 193% over the last seven days, PAHO said in weekly briefing.

Medical workers take care of patients in the emergency room of the Nossa Senhora da Conceicao hospital that is overcrowding because of the coronavirus outbreak, in Porto Alegre, Brazil, March 11, 2021. REUTERS/Diego Vara

Children in the Americas are facing the worst educational crisis ever seen in the region, with millions of children yet to return to classes, according to PAHO, which recommended that countries try to get them safely back to school to protect their social, mental and physical wellbeing.

It urged parents to get their children vaccinated.

Many countries have already authorized and are safely administering COVID vaccines to adolescents, PAHO said.

Last week, the WHO’s expert group on immunization authorized the COVID vaccine developed by Pfizer Inc (PFE.N) for children aged 5 to 12 years, offering a roadmap for countries to roll out vaccines for them, the regional agency said.

Reporting by Anthony Boadle; Editing by David Gregorio

Our Standards: The Thomson Reuters Trust Principles.

 

Reuters source:

https://www.reuters.com/world/americas/covid-19-cases-highest-ever-americas-says-regional-health-agency-2022-01-26

Read More

Continue Reading

Trending